Skye Bioscience Inc (SKYE)

[TrueTrades]

sitting on patent 9,630,941 for suppository and previous japan patent
catalent formulating the delivery product
will it end in another low cost under radar pr event that does nothing to move the pps or shares awaiting interest?
they have no cash
a big heavy partnership to fund development is looking like the only saving grace and they appear armed for it now
time to pull the trigger on this one
next pr could be the big one and a no look back catalyst